| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.4 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |